Search Results

Return to List
Results 1–19 of 19
Title Date
1.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Number 623

(Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format
2.

Ovarian Reserve Testing

Number 618

ABSTRACT The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve commonly known as DOR Although ovarian reserve testing cannot predict the end of ones reproductive years results outside the range expected for a patients a...

January 2015

PDF Format
3.

Influenza Vaccination During Pregnancy

Number 608

(Replaces No. 468, October 2010)

ABSTRACT The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine Influenza vaccination is an essential element of preconception prenatal an...

September 2014

PDF Format
4.

Labor Induction or Augmentation and Autism

Number 597

Abstract Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder ASD Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation some have hypothesized that synthetic oxytocin used...

May 2014

PDF Format
5.

Magnesium Sulfate Use in Obstetrics

Number 573

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

September 2013

PDF Format
6.

Update on Immunization and Pregnancy Tetanus Diphtheria and Pertussis Vaccination

Number 566

(Replaces No. 521, March 2012)

ABSTRACT In the face of dramatic and persistent increases in pertussis disease in the United States the Centers for Disease Control and Preventions Advisory Committee on Immunization Practices has updated its guidelines for the use of the tetanus toxoid reduced diphtheria toxoid and acellular pert...

June 2013

PDF Format
7.

Ethical Issues With Vaccination for the Obstetrician–Gynecologist

Number 564

ABSTRACT Because of the growing importance of infectious disease prevention in the individual patient and the larger community it is vital that Fellows of the American College of Obstetricians and Gynecologists be prepared to navigate the practical and ethical challenges that come with vaccination...

May 2013

PDF Format
8.

Ethical Issues in Pandemic Influenza Planning Concerning Pregnant Women

Number 563

ABSTRACT Pregnant women traditionally have been assigned priority in the allocation of prevention and treatment resources during outbreaks of influenza because of their increased risk of morbidity and mortality The Committee on Ethics of the American College of Obstetricians and Gynecologists expl...

May 2013

PDF Format
9.

Integrating Immunizations Into Practice

Number 558

ABSTRACT Given demonstrated vaccine efficacy safety and the large potential for prevention of many infectious diseases among adults newborns and pregnant women obstetriciangynecologists should embrace immunizations as an integral part of their womens health care practice To provide direct examples...

April 2013

PDF Format
10.

Improving Medication Safety

Number 531

(Reaffirmed 2014, Replaces No. 331, April 2006 and No. 400, March 2008)

ABSTRACT Despite significant national attention medical errors continue to pervade the US health care system Medicationrelated errors consistently rank at the top of all medical errors which account for thousands of preventable deaths annually in the United States There are a variety of methodsran...

August 2012

PDF Format
11.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format
12.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

(Reaffirmed 2013)

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
13.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Reaffirmed 2013, Replaces No. 279, December 2002)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
14.

Nonobstetric Surgery During Pregnancy

Number 474

(Reaffirmed 2013, Replaces No. 284, August 2003)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format
15.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

(Reaffirmed 2013)

ABSTRACT Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
16.

Optimal Goals for Anesthesia Care in Obstetrics

Number 433

(Replaces No. 256, May 2001)

ABSTRACT A joint statement from the American Society of Anesthesiologists and the American College of Obstetricians and Gynecologists was developed to address issues of concern to both specialties Good obstetric care requires the availability of qualified personnel and equipment to administer gene...

May 2009

PDF Format
17.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format
18.

Analgesia and Cesarean Delivery Rates

Number 339

(Reaffirmed 2013, Replaces No. 269, February 2002)

ABSTRACT Neuraxial analgesia techniques are the most effective and least depressant treatments for labor pain The American College of Obstetricians and Gynecologists previously recommended that practitioners delay initiating epidural analgesia in nulliparous women until the cervical dilatation rea...

June 2006

PDF Format
19.

Pain Relief During Labor

Number 295

(Reaffirmed 2008, Replaces No. 231, February 2000)

ABSTRACT Pain management should be provided whenever medically indicated The American Society of Anesthesiologists ASA and the American College of Obstetricians and Gynecologists ACOG believe that women requesting epidural analgesia during labor should not be deprived of this service based on thei...

July 2004

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998